Astria Therapeutics, Inc. acquired by BioCryst for $13 per share, with the deal set to finalize in 1Q26. Click here to read why ATXS stock is a Buy.

Forward earnings” and PEs are biased, create unduly upbeat valuations, weaken the quality of earnings – and thus eventually induce losses.

Within large blend, JPMorgan US Equity-MA stands out for its strong leadership under Scott Davis and the backing of ...

The effects of transcranial direct current stimulation on cortical dynamics depend on the state of consciousness and the stimulation polarity.

Last year, state epidemiologists studied an industrialized region east of Houston. They reported finding high rates of cancer ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Robert Kelly is managing director of XTS Energy LLC, and has more than ...

In February 2024, a shipwreck off Tobago caused a significant surface oil spill, highlighting the need for accurate modeling ...

Six rig drill campaign continues underground; Step-out results from extension drilling at Ming Mine expected in the coming ...

This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...

This study systematically reveals the productivity construction patterns of adjustment wells in the Bohai Oilfield and ...

The ongoing government shutdown showed little impact on consumer sentiment in October University of Michigan survey, though economists expect final data to show a decline. Mark Zandi's analysis ...